GGrantIndex
Sort

146,196 grants matching diabetes

ENDOTHELIUM AND VASCULAR FUNCTION

$1,821,822
Gabor O Kaley · New York Medical College · P01 · FY2007 · HL

Glucose, Insulin in Diabetic Vascular Disease

$1,821,531
Catherine C Hedrick · University Of Virginia · P01 · FY2009 · HL

Genetic Mediators of Metabolic Cardiovascular Disease Risk

$1,820,437
William E Kraus · Duke University · RC2 · FY2009 · HL

Benaroya Research Institute/UCDHSC Autoimmune Cooperative Study Group

$1,820,274
George S Eisenbarth · University Of Colorado Denver · U19 · FY2011 · AI

Coordinating and Bioinformatics Unit for the AMDCC/MMPC

$1,819,749
Richard A McIndoe · Augusta University · U24 · FY2009 · DK

Epidemiology of putative genuine genetic variant: The Women's Health Intiative

$1,818,262
Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2009 · HG

CMPB Pathology Support Group

$1,818,128
Ronald Herbert · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES

ADP-ribosylation Cycles

$1,818,115
Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL

Human pluripotent stem cells

$1,817,771
Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2020 · NS

Molecular Basis of Obesity and Obesity-induced Metabolic Diseases

$1,817,458
Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

Small molecule mimetics of Humanin that normalize neuronal p-Akt as novel therapeutics for AD

$1,817,118
Varghese John · University Of California Los Angeles · RF1 · FY2021 · AG

Infertility Treatment, Child Growth and Development Through Age Three Years

$1,816,962
Edwina Yeung · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD

Collaboration to Improve Blood Pressure in the US Black Belt- Addressing the Triple Threat

$1,816,649
Andrea L Cherrington · University Of Alabama At Birmingham · UH3 · FY2019 · HL

Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes

$1,816,637
Danwei Huangfu · Sloan-Kettering Inst Can Research · UM1 · FY2023 · HG

Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease: 29-year Follow-Up of a Randomized Clinical Trial

$1,814,215
David L Olds · University Of Colorado Denver · R01 · FY2020 · HL

Flow Cytometry

$1,813,825
John McCoy · National Heart, Lung, And Blood Institute · ZIC · FY2020 · HL

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$1,813,730
Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK

Molecular Basis of Obesity and Obesity-induced Metabolic Diseases

$1,813,579
Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Alterations of Sleep and Circadian Timing in Aging

$1,813,578
Phyllis C Zee · Northwestern University At Chicago · P01 · FY2019 · AG

Women's Health Study: Continued Follow-up

$1,813,397
Julie E Buring · Brigham And Women'S Hospital · R01 · FY2012 · CA

HEALTHY COMMUNITIES, TOBACCO CONTROL, DIABETES PREVENTION AND CONTROL, AND BEHAVI

$1,813,350
Sally Pritchard Herndon · Nc State Dept/Hlth & Human Services · U58 · FY2013 · DP

Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)

$1,812,686
Hyon K Choi · Massachusetts General Hospital · U01 · FY2025 · AR

Genetic variant-based drug discovery targeting conserved pathways of aging

$1,812,656
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2021 · AG

Genetic variant-based drug discovery targeting conserved pathways of aging

$1,812,559
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2019 · AG

BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER

$1,812,241
Sloan-Kettering Institute For Cancer Res · P01 · FY2002 · CA